Avita Medical Inc.
Avita Medical Inc. (RCEL): 7 pipeline candidates · 1 upcoming catalyst · ~6 mo cash runway · 2 clinical trials. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
5.7 months
D/E -3.23 · 0% dilution
Lead: Approved
7 candidates
1 upcoming, next in ~30d
10 buys · 0 sells (180d)
A transparent, data-derived signal for Avita Medical Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$126.0M
Cash
$8.3M
Quarterly Burn
$10.1M
Runway
5.7 mo
Revenue
$19.1M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
| Drug | Phase |
|---|---|
| cohealyx | Approved |
| famotidine | Approved |
| permeaderm | Approved |
| recell | Approved |
| recell go | Preclinical |
| recell system | Approved |
| sodium phenyl | Approved |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
78
Total value held
$189.8M
| Holder | Shares | Value |
|---|---|---|
| orbimed advisors llc | 41,510,995 | $156.5M |
| vanguard capital management llc | 2,670,304 | $9.9M |
| eversource wealth advisors, llc | 102,535 | $9.7M |
| blackrock, inc. | 1,133,126 | $4.2M |
| geode capital management, llc | 542,974 | $2.0M |
| state street corp | 429,022 | $1.6M |
| vanguard fiduciary trust co | 193,436 | $716K |
| northern trust corp | 183,181 | $678K |
| morgan stanley | 157,621 | $583K |
| goldman sachs group inc | 99,845 | $369K |
Showing top 10 of 78 institutional holders of Avita Medical Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Avita Medical Inc.'s pipeline?
Avita Medical Inc. (RCEL) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Avita Medical Inc.'s lead drug candidate?
Avita Medical Inc.'s most advanced tracked candidate is cohealyx (Approved) for Full-thickness wounds and burns.
What is Avita Medical Inc.'s next catalyst?
Avita Medical Inc.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: DUEXIS" — expected July 18, 2026.
What is Avita Medical Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Avita Medical Inc. has approximately 5.7 months of cash runway.
What is Avita Medical Inc.'s market capitalization?
Avita Medical Inc.'s market capitalization is approximately $126.0M.
Get the full picture on Avita Medical Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.